Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Artu Biologicals Europe
Lelystad, Flevoland, Netherlandsalk.net ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Artu Biologicals is a Dutch biotechnology company specializing in the field of allergy immunotherapy (AIT). Based in Lelystad, the company develops and manufactures allergen extracts for both diagnostic purposes and subcutaneous immunotherapy (SCIT) treatments. Since its acquisition by the Danish pharmaceutical company ALK-Abelló in 2007, Artu Biologicals has functioned as a specialized production and research facility within the global ALK network. Its product portfolio primarily addresses respiratory allergies such as allergic rhinitis and allergic asthma. The company is recognized for its expertise in the standardization and production of high-quality allergen preparations.
- Therapeutic areas
- Immunology
- Modalities
- Allergen extractBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on Artu Biologicals Europe.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Artu Biologicals Europe.